S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:BWAY

BrainsWay (BWAY) Stock Forecast, Price & News

$1.93
+0.21 (+12.21%)
(As of 06/5/2023 ET)
Compare
Today's Range
$1.79
▼
$2.01
50-Day Range
$1.46
▼
$1.82
52-Week Range
$1.38
▼
$7.00
Volume
135,472 shs
Average Volume
72,373 shs
Market Capitalization
$32.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

BrainsWay MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
245.4% Upside
$6.67 Price Target
Short Interest
Healthy
0.04% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of BrainsWay in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.25) to ($0.16) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

445th out of 985 stocks

Surgical & Medical Instruments Industry

46th out of 97 stocks

See Top Rated MarketRank™ Stocks Here

BWAY stock logo

About BrainsWay (NASDAQ:BWAY) Stock

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

June 5, 2023 | markets.businessinsider.com
The Latest Analyst Ratings for BrainsWay
June 5, 2023 | markets.businessinsider.com
H.C. Wainwright Keeps Their Buy Rating on Brainsway (BWAY)
June 5, 2023 | Legacy Research (Affiliate) (Ad)
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
May 23, 2023 | markets.businessinsider.com
BrainsWay Appoints Ido Marom To Succeed Scott Areglado As CFO
May 23, 2023 | msn.com
BrainsWay appoints CFO
May 23, 2023 | finance.yahoo.com
BrainsWay Announces Appointment of Ido Marom as CFO
May 23, 2023 | americanbankingnews.com
Equities Analysts Set Expectations for BrainsWay Ltd.'s FY2023 Earnings (NASDAQ:BWAY)
May 22, 2023 | americanbankingnews.com
BrainsWay (NASDAQ:BWAY) Given New $3.00 Price Target at Raymond James
June 5, 2023 | Legacy Research (Affiliate) (Ad)
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
May 18, 2023 | markets.businessinsider.com
BrainsWay - Aiming For Revenue Growth And Profitability
May 17, 2023 | msn.com
BrainsWay: Q1 Earnings Insights
May 16, 2023 | msn.com
Earnings Outlook For BrainsWay
May 16, 2023 | americanbankingnews.com
BrainsWay (BWAY) Set to Announce Quarterly Earnings on Wednesday
May 12, 2023 | finance.yahoo.com
Brainsway Ltd. Sponsored ADR (BWAY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
May 11, 2023 | americanbankingnews.com
Short Interest in BrainsWay Ltd. (NASDAQ:BWAY) Decreases By 64.2%
May 6, 2023 | ca.finance.yahoo.com
BrainsWay Ltd. (BWAY) Stock Historical Prices & Data - Yahoo Finance
May 3, 2023 | finance.yahoo.com
BrainsWay to Report First Quarter 2023 Financial Results on May 17, 2023
May 2, 2023 | finance.yahoo.com
BrainsWay to Participate in Clinical TMS Society and American Psychiatric Association Meetings
April 19, 2023 | yahoo.com
Smash, the Canceled TV Musical, to Become a Broadway Musical (For Real)
April 18, 2023 | americanbankingnews.com
HC Wainwright Weighs in on BrainsWay Ltd.'s FY2024 Earnings (NASDAQ:BWAY)
April 14, 2023 | americanbankingnews.com
BrainsWay (NASDAQ:BWAY) Price Target Cut to $12.00
April 14, 2023 | americanbankingnews.com
BrainsWay (NASDAQ:BWAY) versus Akili (NASDAQ:AKLI) Head to Head Review
March 29, 2023 | marketwatch.com
BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS(TM) in Treating Depression and Anxious Depression
March 29, 2023 | finance.yahoo.com
BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression
March 29, 2023 | americanbankingnews.com
Oppenheimer Comments on BrainsWay Ltd.'s Q1 2023 Earnings (NASDAQ:BWAY)
March 28, 2023 | finance.yahoo.com
BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression
March 22, 2023 | americanbankingnews.com
Research Analysts Set Expectations for BrainsWay Ltd.'s Q1 2023 Earnings (NASDAQ:BWAY)
See More Headlines

BWAY Price History

BWAY Company Calendar

Last Earnings
3/15/2023
Today
6/05/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BWAY
CUSIP
N/A
CIK
1505065
Web
www.brainsway.com
Phone
(722) 582-4030
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.67
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+274.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,350,000.00
Net Margins
-53.37%
Pretax Margin
-52.21%
Return on Equity
-28.89%
Return on Assets
-20.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
5.61

Sales & Book Value

Annual Sales
$27.18 million
Price / Sales
1.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.75 per share
Price / Book
0.65

Miscellaneous

Outstanding Shares
16,580,000
Free Float
13,430,000
Market Cap
$29.51 million
Optionable
Not Optionable
Beta
0.94

Key Executives

  • Hadar Levy
    Chief Executive Officer
  • Richard Scott Areglado
    Chief Financial Officer & Senior Vice President
  • Yiftach Roth
    Chief Scientific Officer
  • Moria Ben Soussan Ankri
    Vice President-Research & Development
  • Aron Tendler
    Chief Medical Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













BWAY Stock - Frequently Asked Questions

Should I buy or sell BrainsWay stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BWAY shares.
View BWAY analyst ratings or view top-rated stocks.

What is BrainsWay's stock price forecast for 2023?

3 analysts have issued twelve-month price targets for BrainsWay's stock. Their BWAY share price forecasts range from $3.00 to $12.00. On average, they anticipate the company's share price to reach $6.67 in the next year. This suggests a possible upside of 274.5% from the stock's current price.
View analysts price targets for BWAY or view top-rated stocks among Wall Street analysts.

How have BWAY shares performed in 2023?

BrainsWay's stock was trading at $2.47 at the beginning of the year. Since then, BWAY stock has decreased by 27.9% and is now trading at $1.78.
View the best growth stocks for 2023 here.

When is BrainsWay's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our BWAY earnings forecast.

How were BrainsWay's earnings last quarter?

BrainsWay Ltd. (NASDAQ:BWAY) released its earnings results on Wednesday, March, 15th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.12). The business earned $6.03 million during the quarter, compared to the consensus estimate of $6.10 million. BrainsWay had a negative trailing twelve-month return on equity of 28.89% and a negative net margin of 53.37%.

What other stocks do shareholders of BrainsWay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BrainsWay investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Pfizer (PFE), Neuronetics (STIM), Boingo Wireless (WIFI), Ampio Pharmaceuticals (AMPE), Eastman Chemical (EMN), Enbridge (ENB) and Energy Transfer (ET).

When did BrainsWay IPO?

(BWAY) raised $30 million in an initial public offering (IPO) on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

What is BrainsWay's stock symbol?

BrainsWay trades on the NASDAQ under the ticker symbol "BWAY."

Who are BrainsWay's major shareholders?

BrainsWay's stock is owned by many different institutional and retail investors. Top institutional investors include Wasatch Advisors LP (6.00%), Renaissance Technologies LLC (0.19%) and Good Life Advisors LLC (0.11%).

How do I buy shares of BrainsWay?

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BrainsWay's stock price today?

One share of BWAY stock can currently be purchased for approximately $1.78.

How much money does BrainsWay make?

BrainsWay (NASDAQ:BWAY) has a market capitalization of $29.51 million and generates $27.18 million in revenue each year. The company earns $-13,350,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.

How can I contact BrainsWay?

BrainsWay's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518. The official website for the company is www.brainsway.com. The company can be reached via phone at (722) 582-4030 or via email at hadarl@brainsway.com.

This page (NASDAQ:BWAY) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -